Harnessing the power of real-world evidence is critical to scaling precision medicine. Christina Lopes, Co-Founder & CEO of FidoCure, shares how the company built a canine cancer dataset and leveraged AI to transform data points into targeted therapies, driving adoption beyond oncology specialists and enabling validated and scalable solutions.
Session Topics:
Milestone - AI Breakthrough
AI
Data
Oncology
Precision Medicine
Canine
Speaker(s):
Christina Lopes
Co-Founder and CEO
FidoCure
Time:
9.50am - 10.10am
Agenda Track No.:
Track 2
Summary:
Session Will be Recorded - Attend live or Watch On-Demand
Session Type:
General Session (Presentation)